Bioqual EBITDA Margin 2010-2024 | BIOQ

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bioqual (BIOQ) over the last 10 years. The current EBITDA margin for Bioqual as of November 30, 2024 is .
Bioqual EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-11-30 $0.05B $0.00B 2.00%
2024-08-31 $0.06B $0.00B 5.45%
2024-05-31 $0.06B $0.01B 10.17%
2024-02-29 $0.06B $0.01B 11.11%
2023-11-30 $0.06B $0.01B 8.06%
2023-08-31 $0.06B $0.01B 15.87%
2023-05-31 $0.06B $0.01B 11.11%
2023-02-28 $0.07B $0.01B 10.77%
2022-11-30 $0.07B $0.01B 14.71%
2022-08-31 $0.07B $0.01B 16.67%
2022-05-31 $0.07B $0.01B 21.54%
2022-02-28 $0.06B $0.02B 23.44%
2021-11-30 $0.06B $0.02B 25.00%
2021-08-31 $0.06B $0.01B 20.34%
2021-05-31 $0.06B $0.01B 22.03%
2021-02-28 $0.06B $0.01B 12.73%
2020-11-30 $0.05B $0.01B 12.96%
2020-08-31 $0.05B $0.01B 11.76%
2020-05-31 $0.05B $0.01B 10.87%
2020-02-29 $0.05B $0.02B 42.22%
2019-11-30 $0.04B $0.02B 41.86%
2019-08-31 $0.04B $0.02B 42.50%
2019-05-31 $0.04B $0.02B 60.00%
2019-02-28 $0.04B $0.02B 57.89%
2018-11-30 $0.04B $0.03B 80.56%
2018-08-31 $0.04B $0.04B 100.00%
2018-05-31 $0.04B $0.04B 100.00%
2018-02-28 $0.04B $0.04B 100.00%
2017-11-30 $0.04B $0.04B 100.00%
2017-08-31 $0.04B $0.04B 100.00%
2017-05-31 $0.04B $0.04B 100.00%
2017-02-28 $0.04B $0.04B 100.00%
2016-11-30 $0.04B $0.04B 100.00%
2016-08-31 $0.04B $0.04B 100.00%
2016-05-31 $0.03B $0.03B 100.00%
2016-02-29 $0.03B $0.03B 100.00%
2015-11-30 $0.03B $0.03B 100.00%
2015-08-31 $0.03B $0.03B 100.00%
2015-05-31 $0.03B $0.03B 100.00%
2015-02-28 $0.03B $0.03B 100.00%
2014-08-31 $0.02B $0.02B 100.00%
2014-05-31 $0.02B $0.02B 100.00%
2013-11-30 $0.02B $0.02B 100.00%
2013-08-31 $0.02B $0.02B 100.00%
2013-05-31 $0.02B $0.02B 100.00%
2012-05-31 $0.02B $0.02B 100.00%
2012-02-29 $0.02B $0.02B 100.00%
2011-11-30 $0.02B $0.02B 100.00%
2011-08-31 $0.02B $0.02B 100.00%
2011-05-31 $0.02B $0.02B 100.00%
2011-02-28 $0.04B $0.04B 100.00%
2010-11-30 $0.04B $0.04B 100.00%
2010-08-31 $0.04B $0.04B 100.00%
2010-05-31 $0.04B $0.04B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.054B $0.059B
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.312B 0.00
Quest Diagnostics (DGX) United States $18.153B 18.23
DaVita (DVA) United States $14.110B 18.25
Encompass Health (EHC) United States $9.934B 22.26
Chemed (CHE) United States $8.335B 25.62
Elanco Animal Health (ELAN) United States $5.917B 14.08
Option Care Health (OPCH) United States $5.245B 24.85
RadNet (RDNT) United States $4.764B 105.51
LifeStance Health (LFST) United States $3.053B 0.00
Amedisys (AMED) United States $3.017B 21.47
Addus HomeCare (ADUS) United States $2.171B 25.48
Astrana Health (ASTH) United States $2.001B 27.37
U.S Physical Therapy (USPH) United States $1.324B 34.81
Aveanna Healthcare Holdings (AVAH) United States $0.935B 0.00
Pennant (PNTG) United States $0.935B 37.81
Atai Life Sciences (ATAI) Germany $0.356B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00